(Q35234491)

English

EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Adaptive radiation therapy

0 references

pancreatic cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

John Nemunaitis

4

object named as

John Nemunaitis

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

author name string

J Randolph Hecht

1

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

James J Farrell

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Neil Senzer

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Alexander Rosemurgy

5

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Theodore Chung

6

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Nader Hanna

7

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Kenneth J Chang

8

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Milind Javle

9

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Mitchell Posner

10

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Irving Waxman

11

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Anthony Reid

12

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Richard Erickson

13

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Marcia Canto

14

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Amitabh Chak

15

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Gretta Blatner

16

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Milan Kovacevic

17

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Mark Thornton

18

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

language of work or name

0 references

publication date

1 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Gastrointestinal Endoscopy

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

75

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

332-338

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

13 July 2018

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

13 July 2018

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

13 July 2018

RECIST revisited: a review of validation studies on tumour assessment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

13 July 2018

Treatment for pancreatic cancer: current therapy and continued progress

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

13 July 2018

Pancreatic cancer: basic and clinical aspects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

13 July 2018

TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

13 July 2018

Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

13 July 2018

Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

13 July 2018

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

13 July 2018

Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

13 July 2018

Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

13 July 2018

Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

13 July 2018

Tumor necrosis factor (TNF).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

13 July 2018

The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

13 July 2018

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

13 July 2018

Serum CA19-9 decline compared to radiographic response as a surrogate for clinical outcomes in patients with metastatic pancreatic cancer receiving chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

26 September 2018

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

26 September 2018

Risk of venous thrombosis in patients with pancreatic adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

26 September 2018

A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

26 September 2018

Tumor necrosis factor-alpha-based gene therapy enhances radiation cytotoxicity in human prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

26 September 2018

Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

26 September 2018

Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

26 September 2018

Spatial and temporal control of gene therapy using ionizing radiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

26 September 2018

Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4380192

15 November 2018

CA 19-9 is an index of response to neoadjunctive chemoradiation therapy in pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22248601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents

1 reference

https://pubmed.ncbi.nlm.nih.gov/22248601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic Resections after Chemoradiotherapy for Locally Advanced Ductal Adenocarcinoma: Analysis of Perioperative Outcome and Survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/22248601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22248601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TNF modulates endothelial properties by decreasing cAMP

1 reference

https://pubmed.ncbi.nlm.nih.gov/22248601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant therapy for unresectable pancreatic adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22248601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation therapy combined with Adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma. Gastrointestinal Tumor Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22248601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22248601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22248601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Venous thrombosis in patients with solid tumors: determination of frequency and characteristics

1 reference

https://pubmed.ncbi.nlm.nih.gov/22248601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22248601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour necrosis factor mediates the survival benefit of interleukin 2 in a murine pulmonary metastases model

1 reference

https://pubmed.ncbi.nlm.nih.gov/22248601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.GIE.2011.10.007

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35234491&oldid=1978975994"